Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xerostomia-optimised Intensity-modulated Radiotherapy Versus Standard Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma Patients:a Multicenter Non-inferior Randomized Controlled Phase III Clinical Trial

NCT06282497 is registered in ClinicalTrials.gov with Zhongshan People's Hospital, Guangdong, China as lead sponsor.

NCT NCT06282497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06282497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xerostomia-optimised Intensity-modulated Radiotherapy Versus Standard Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma Patients:a Multicenter Non-inferior Randomized Controlled Phase III Clinical Trial
Lead sponsor
Zhongshan People's Hospital, Guangdong, China
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2023
Completion date
October 23, 2029
Enrollment
524 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma ,xerostomia,radiotherapy